As such, we leveraged WES to identify variants causing dystroglycanopathies and merosin-deficient CMD, several of which were novel or reported for the first time in Egypt. This evidence concerns the gene LAMA2 and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan.